APGDI
FDA Approved Drugs

APGDI

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 3
  • Latest Approval Date Mar 25, 2021
  • Data Source FDA
  • First Approval Date Jun 28, 2012
Company Overview

Company

APGDI

Country

U.S.A

Website

Email

Social Profiles

Company Snapshot

APGDI

U.S.A

View on Map
FDA Approved Drug Records ( 3 records )
2012
28 Jun
RX Application: 202611

Drug Name

MYRBETRIQ

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2012-06-28

202611 / 1

Active Ingredient

MIRABEGRON

Application Number

202611

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2012-06-28

Regulatory Status

RX

2012
28 Jun
RX Application: 202611

Drug Name

MYRBETRIQ

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2012-06-28

202611 / 2

Active Ingredient

MIRABEGRON

Application Number

202611

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2012-06-28

Regulatory Status

RX

2021
25 Mar
RX Application: 213801

Drug Name

MYRBETRIQ GRANULES

Product Number

1

Dosage Form

-

Strength

8MG/ML

Approval Date

2021-03-25

213801 / 1

Active Ingredient

MIRABEGRON

Application Number

213801

Product Number

1

Dosage Form

-

Strength

8MG/ML

Approval Date

2021-03-25

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    3 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
3 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

MYRBETRIQ

Application Number

202611

Product Number

1

Active Ingredient

MIRABEGRON

Dosage Form

-

Strength

25MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.